$45M additional funding bolsters development of canine longevity drug

By /

 

Photo courtesy John Poisson

Loyal, a biotechnology company developing longevity medications for dogs, has announced the conclusion of its Series B financing phase, securing $45 million in investment, with Bain Capital Ventures spearheading the round. With this latest investment, Loyal has amassed over $125 million in funds since its establishment in 2019.

“This fundraise fuels our efforts to bring to market what we hope will be the first U.S. Food & Drug Administration (FDA)-approved drug to extend healthy lifespan,” says Celine Halioua, founder and CEO of Loyal. “All of our work is centered on giving dogs longer, healthier lives. I’m proud of the work the team has done to date, and we have a very important and challenging vision to realize. I’m excited to work with our new and existing investors and continue to make FDA-approved dog longevity drugs a reality.”

Loyal reports this funding series will support the continued development of the drug, with expected product launch in early 2025 pending FDA approval.

This funding follows several significant milestones for the company, including:

  • Earning what Loyal believes to be the FDA’s first-ever formal acceptance a drug can be developed and approved to extend lifespan. FDA review is being led by the agency’s Center for Veterinary Medicine.
  • Completing the technical effectiveness section of the conditional approval application for LOY-001’s use in large dog lifespan extension.
  • Launching the STAY study, the pivotal effectiveness study for LOY-002, in development for dog lifespan extension. STAY will include more than 1,000 dogs across over 50 veterinary sites in the United States.
  • Continued progress towards the other FDA dossier approvals necessary for LOY-002 conditional market approval in early 2025.

Loyal is currently working on three medications aimed at prolonging the healthy lifespan of dogs: LOY-001 and LOY-003 tailored to enhance the healthy lifespan of large-breed dogs, and LOY-002 is specifically designed for senior dogs weighing 14 pounds and above.

For more information, visit the website of Loyal.

Scroll to Top